Literature DB >> 10372727

Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.

W Arlt1, J Haas, F Callies, M Reincke, D Hübler, M Oettel, M Ernst, H M Schulte, B Allolio.   

Abstract

The most abundant human steroids, dehydroepiandrosterone (DHEA) and its sulfate ester DHEAS, may have a multitude of beneficial effects, but decline with age. DHEA possibly prevents immunosenescence, and as a neuroactive steroid it may influence processes of cognition and memory. Epidemiological studies revealed an inverse correlation between DHEAS levels and the incidence of cardiovascular disease in men, but not in women. To define a suitable dose for DHEA substitution in elderly men we studied pharmacokinetics and biotransformation of orally administered DHEA in 14 healthy male volunteers (mean age, 58.8 +/- 5.1 yr; mean body mass index, 25.5 +/- 1.5 kg/m2) with serum DHEAS concentrations below 4.1 micromol/L (1500 ng/mL). Diurnal blood sampling was performed on 3 occasions in a single dose, randomized, cross-over design (oral administration of placebo, 50 mg DHEA, or 100 mg DHEA). The intake of 50 mg DHEA led to an increase in serum DHEAS to mean levels of young adult men, whereas 100 mg DHEA induced supraphysiological concentrations [placebo vs. 50 mg DHEA vs. 100 mg DHEA; area under the curve (AUC) 0-12 h (mean +/- SD) for DHEA, 108 +/- 22 vs. 252 +/- 45 vs. 349 +/- 72 nmol/L x h; AUC 0-12 h for DHEAS, 33 +/- 9 vs. 114 +/- 19 vs. 164 +/- 36 micromol/L x h]. Serum testosterone and dihydrotestosterone remained unchanged after DHEA administration. In contrast, 17beta-estradiol and estrone significantly increased in a dose-dependent manner to concentrations still within the upper normal range for men [placebo vs. 50 mg DHEA vs. 100 mg DHEA; AUC 0-12 h for 17beta-estradiol, 510 +/- 198 vs. 635 +/- 156 vs. 700 +/- 209 pmol/L x h (P < 0.0001); AUC 0-12 h for estrone, 1443 +/- 269 vs. 2537 +/- 434 vs. 3254 +/- 671 pmol/L x h (P < 0.0001)]. In conclusion, 50 mg DHEA seems to be a suitable substitution dose in elderly men, as it leads to serum DHEAS concentrations usually measured in young healthy adults. The DHEA-induced increase in circulating estrogens may contribute to beneficial effects of DHEA in men.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372727     DOI: 10.1210/jcem.84.6.5789

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Monogenic Disorders of Adrenal Steroidogenesis.

Authors:  Elizabeth S Baranowski; Wiebke Arlt; Jan Idkowiak
Journal:  Horm Res Paediatr       Date:  2018-06-06       Impact factor: 2.852

2.  Effect of acute DHEA administration on free testosterone in middle-aged and young men following high-intensity interval training.

Authors:  Te-Chih Liu; Che-Hung Lin; Chih-Yang Huang; John L Ivy; Chia-Hua Kuo
Journal:  Eur J Appl Physiol       Date:  2013-02-17       Impact factor: 3.078

3.  Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study.

Authors:  Michael A Ghebre; Deborah J Hart; Alan J Hakim; Bernet S Kato; Vicky Thompson; Nigel K Arden; Tim D Spector; Guangju Zhai
Journal:  Calcif Tissue Int       Date:  2011-07-26       Impact factor: 4.333

4.  Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.

Authors:  Catherine M Jankowski; Wendolyn S Gozansky; John M Kittelson; Rachael E Van Pelt; Robert S Schwartz; Wendy M Kohrt
Journal:  J Clin Endocrinol Metab       Date:  2008-09-23       Impact factor: 5.958

Review 5.  Androgen therapy with dehydroepiandrosterone.

Authors:  Jacques Buvat
Journal:  World J Urol       Date:  2003-10-10       Impact factor: 4.226

Review 6.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice.

Authors:  L Wang; Y-D Wang; W-J Wang; D-J Li
Journal:  Osteoporos Int       Date:  2008-08-09       Impact factor: 4.507

Review 8.  [Replacement therapy with adrenal steroids].

Authors:  S Hahner; B Allolio
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

Review 9.  Might DHEA be considered a beneficial replacement therapy in the elderly?

Authors:  Alessandro D Genazzani; Chiara Lanzoni; Andrea R Genazzani
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 10.  A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?

Authors:  Nikolaos Samaras; Dimitrios Samaras; Emilia Frangos; Alexandre Forster; Jacques Philippe
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.